As the fight against cancer intensifies, a promising new advancement in therapy has emerged through a study combining nadunolimab with pembrolizumab. Reported in the journal Investigational New Drugs, the CIRIFOUR trial explored the efficacy of these drugs in patients with solid tumors. This study
In the rapidly evolving field of medical research, a new compound known as DT-109 has emerged as a beacon of hope for patients suffering from heart and liver diseases. Developed at the University of Michigan, this glycine-based compound was initially created to tackle metabolic
In the vast realm of medical advancements, the emergence of Zevaskyn, an innovative gene therapy, offers new hope for patients grappling with recessive dystrophic epidermolysis bullosa (RDEB). This severe genetic disorder, characterized by fragile skin prone to blistering, requires groundbreaking
The relentless progression of Alzheimer's disease, a debilitating neurodegenerative condition, has been closely linked to the misbehavior of two primary proteins: amyloid-beta and tau. Over the years, scientific efforts have primarily focused on addressing amyloid-beta, leading to some success
Despite increasing investments and rising costs, the pharmaceutical industry's internal rate of return (IRR) from research and development (R&D) has been on a downward trajectory for decades. Recently, however, an analysis indicates the possibility of a resurgence in R&D returns, a
Victoria has embarked on a groundbreaking journey aiming to establish itself as a leading force in global cancer research. Through the Cancer Council Research Fellowships Victoria (CRFV) program, the Victorian Government, in collaboration with Cancer Council Victoria, seeks to reshape the landscape
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53
